United States · FDA National Drug Code directory
Tizanidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85534-0030_55101a36-ba0a-5358-e063-6394a90a0324
- Product NDC
- 85534-0030
- Form
- TABLET
- Composition / generic term
- Tizanidine
- Labeler
- HAWAII REPACK, INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20020703
- Source listing expiry
- 20271231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET in 1 BOTTLE (85534-0030-0) · 85534-0030-0
- 20 TABLET in 1 BOTTLE (85534-0030-1) · 85534-0030-1
- 30 TABLET in 1 BOTTLE (85534-0030-2) · 85534-0030-2
- 60 TABLET in 1 BOTTLE (85534-0030-3) · 85534-0030-3
- 90 TABLET in 1 BOTTLE (85534-0030-4) · 85534-0030-4
- 120 TABLET in 1 BOTTLE (85534-0030-5) · 85534-0030-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →